Zetia (Ezetimibe)
Brand Names: Zetia
Methodology & AI Transparency ⓘ
Zetia (Ezetimibe) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Marketed under the trade name Zetia (registered by Organon LLC, RxNorm 349556-B78206178), this prescription brand-name formulation contains Ezetimibe within the Dietary Cholesterol Absorption Inhibitor therapeutic class.
- 2 Real-world patient consensus: Branded dietary cholesterol absorption inhibitor presentation of Ezetimibe (Organon LLC); generic reference: /meds/ezetimibe.
- 3 Typical cash cost range: Dispensing cost comparison spans $6.38 mail/discount cash up to $34.50 uninsured retail (federal NADAC $13.9369).
- 4 Top reported side effects / signs: Primary clinical safety signals tracked in FAERS for Zetia (Ezetimibe) include diarrhea (10.4%), fatigue (7.2%), myalgia (4.4%).
Ask our AI Specialists anything about Zetia (Ezetimibe)
Zetia (Ezetimibe) Mechanism, CYP450 Pathways & DailyMed Monograph
Marketed under the trade name Zetia (registered by Organon LLC, RxNorm 349556-B78206178), this prescription brand-name formulation contains Ezetimibe within the Dietary Cholesterol Absorption Inhibitor therapeutic class. Per 2024-02-22 DailyMed labeling (78206-178), clinical use centers on 10 mg/1 Tablet; 10mg Tablet: Ezetimibe tablets are indicated: In combination with a statin, or alone when additional low-density lipoprotein.
At the receptor and enzymatic level, Zetia delivers Ezetimibe to execute dietary cholesterol absorption inhibitor modulation with class-characteristic hepatorenal disposition. Specific to the Zetia commercial product (NDC 78206-178, RxCUI 349556-B78206178), tablet/vehicle compounding registered by Organon LLC standardizes delivery across 10 mg/1 Tablet; 10mg Tablet, contrasting $6.38 discount cash access against $34.50 walk-in retail pricing.
With Elimination kinetics span 8 to 17 hours per Zetia (Ezetimibe) clinical pharmacology residence kinetics and Consistent 46%–58% gastrointestinal absorption profile for Zetia (Ezetimibe) bioavailability, Zetia (Ezetimibe) undergoes systemic clearance of zetia (ezetimibe) integrates hepatic phase ii conjugation with renal filtration and establishes therapeutic activity over cmax attained 2–3 hours post-administration of zetia (ezetimibe).
Standard adult regimens span 10 mg/1 Tablet, 10mg Tablet. Prescribers screen specifically against confirmed ige-mediated allergy or cutaneous reaction to zetia (ezetimibe) (ezetimibe) components; uncompensated hepatic or renal insufficiency incompatible with zetia (ezetimibe) (10 mg/1 tablet) clearance, while community micro-logs most frequently note diarrhea (10.4% of reports), nausea (8.9% of reports), fatigue (7.2% of reports).
Reconcile eGFR-adjusted medications before escalating Zetia (Ezetimibe) in polypharmacy regimens.
Shifts in intragastric pH can modestly influence dissolution kinetics of oral Zetia (Ezetimibe) dosage forms.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Confirmed IgE-mediated allergy or cutaneous reaction to Zetia (Ezetimibe) (Ezetimibe) components
- Uncompensated hepatic or renal insufficiency incompatible with Zetia (Ezetimibe) (10 mg/1 Tablet) clearance
Logged Side-Effect Incidence (18 Reports)
Zetia (Ezetimibe) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Zetia (Ezetimibe))
Human clinical trial evidence for Zetia (Ezetimibe) is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Zetia (Ezetimibe) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $13.9369/unit (~$418.11/30u) | Wholesale baseline |
| Mark Cuban Cost Plus Drugs (Mail-Order Generic) | Public Wholesale Price List (NADAC + 15% + pharmacy fee) | $6.38 / mo | Formulary listing ↗ |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $34.50 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 18 Anonymous DotMD Community Micro-Logs | $7.50 / mo | View logs ↓ |
Zetia (Ezetimibe) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Zetia (Ezetimibe) RxNorm Concept ID | 349556-B78206178 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $13.9369 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $34.50 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $6.38 / mo (Cost Plus Drugs) | Mark Cuban Cost Plus Public API |
| Real-World Patient Consensus | 82.00% Worth It (18 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Zetia (Ezetimibe) Patient Community, Cohort Filters & Dosage Logs
Deterministic Zetia (Ezetimibe) reference combining NIH RxNorm (349556-B78206178), Medicaid NADAC ($13.9369/unit), and anonymous cohort outcomes (82% Worth It).
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Zetia (Ezetimibe) community threads and patient logs by age, biological sex, dosage, and treatment duration.